Market giant CSL has helped offset losses on the Australian share market after revealing it is starting to collect more plasma for its therapies despite the pandemic.
Market giant CSL has helped offset losses on the Australian share market after revealing it is starting to collect more plasma for its therapies despite the pandemic.